Crow Point Partners’s Dynavax Technologies DVAX Stock Holding History

Crow Point Partners’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$199K	Buy	35,617 +2,632	+8%	+$14.1K	0.31%	66
2019 Q3	$117K	Hold	32,985	–	–	0.02%	115
2019 Q2	$132K	Hold	32,985	–	–	0.02%	114
2019 Q1	$241K	Hold	32,985	–	–	0.04%	97
2018 Q4	$285K	Buy	32,985 +9,977	+43%	+$110K	0.05%	85
2018 Q3	$285K	Buy	23,008 +1,761	+8%	+$23.8K	0.05%	118
2018 Q2	$325K	Buy	21,247 +17,757	+509%	+$307K	0.06%	83
2018 Q1	$69K	Buy	+3,490	New	+$60.3K	0.01%	171

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

BCPEMI

Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Crow Point Partners's DVAX Position: Q4 2019 in Review

Crow Point Partners increased its Dynavax Technologies (DVAX) stake by 8% in Q4 2019, buying an estimated $14.1K and bringing the position to 35,617 shares worth $199K. The position accounts for 0.31% of the portfolio, ranked #66.

Crow Point Partners first reported a position in DVAX in Q1 2018 and has held it in 8 quarters since. The position peaked at $325K in Q2 2018. 123 funds tracked by Wall St. Rank hold DVAX as of Q4 2019.

Crow Point Partners held 35,617 shares of Dynavax Technologies worth $199K as of Q4 2019.
Crow Point Partners bought 2,632 Dynavax Technologies shares in Q4 2019, an estimated $14.1K.
Dynavax Technologies made up 0.31% of Crow Point Partners's portfolio in Q4 2019, its #66 holding.
Crow Point Partners first reported a position in Dynavax Technologies in Q1 2018 and has held it in 8 quarters since.
Crow Point Partners's Dynavax Technologies position peaked at $325K in Q2 2018.
123 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.